Dr. Inhorn is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2013 S. Jefferson St., Second Floor
Roanoke, VA 24014- Is this information wrong?
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1988
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1985
Johns Hopkins University School of MedicineClass of 1982
Certifications & Licensure
ME State Medical License 2019 - 2024
WV State Medical License 1989 - 2006
VA State Medical License 1988 - 2024
IN State Medical License 1985 - 2003
IL State Medical License 1982 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
Publications & Presentations
PubMed
- 22 citationsPixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.David Belada, Pencho Georgiev, Shaker R. Dakhil, Lowell F Inhorn, David Andorsky, J. Thaddeus Beck, Donald Quick, Ruth Pettengell, Robert Daly, James P Dean, Mariya Pa...> ;Future Oncology. 2016 Apr 20
- Studies with 17 beta(16 alpha-[125i]iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors.Gatley, S. J., Shaughnessy, W. J., Inhorn, L., Leiberman, L. M.> ;J Nucl Med. 1981 May
- 7 citationsCellular control of in vitro progression of murine myeloid leukemia: progression accompanies acquisition of independence from growth factor and stromal cells.Boswell Hs, Arun Srivastava, J. S. Burgess, P. Nahreini, Nyla A. Heerema, L. Inhorn, F. Padgett, E. B. Walker, R. W. Geib> ;Leukemia. 1987 Nov 1
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Carilion Franklin Memorial HospitalRocky Mount, Virginia
Carilion Roanoke Memorial HospitalRoanoke, Virginia
Lewis-Gale Medical CenterBoones Mill, Virginia
Maine Medical CenterPortland, Maine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
